The Independent Voice of
European Private Equity

Advanced Search

HIG Capital’s Aspire Pharma acquires Morningside

Jennifer Forrest 3 October 2022

HIG Capital-backed Aspire Pharma has acquired Morningside Healthcare and Morningside Pharmaceuticals, a UK provider of niche generic and branded speciality pharmaceuticals.

Related Articles

Experienced Capital strengthens food portfolio with Paris bakery investment

20/05/24

Kester Capital portcos complete two strategic add-ons

20/05/24

Enterprise Investors acquires facility management provider Sescom

20/05/24

Battery to acquire Germany’s Steute Technologies

20/05/24

Liberty, Opportunity, Private Equity

20/05/24

Amplio-backed Selatek acquires Newsafe

20/05/24